LOC102723888: A Potential Drug Target or Biomarker (G102723888)

Target Name: Uncharacterized LOC102723888, transcript variant X1

NCBI ID: G102723888

Uncharacterized LOC102723888, transcript variant X1

Other Name(s): LOC102723888 variant X1

LOC102723888: A Potential Drug Target or Biomarker

LOC102723888 is a gene located on chromosome 10q34.3 has been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is known to regulate gene expression. The primary aim of this article is to provide an in-depth analysis of LOC102723888, its potential drug target status, and its potential as a biomarker.

LOC102723888: A Non-Coding RNA Molecule

LOC102723888 is a non-coding RNA molecule that is known to regulate gene expression. It is composed of 194 amino acid residues and has a calculated molecular weight of 20 kDa. LOC102723888 is located on chromosome 10q34.3 and has been observed to be expressed in various tissues and organs.

Potential Drug Target

LOC102723888 has been predicted to be a potential drug target due to its unique structure and the various functions it is known to regulate. It is known to play a role in cell adhesion, migration, and invasion. LOC102723888 has also been shown to be involved in the regulation of cell cycle progression and the apoptosis process. These functions make LOC102723888 an attractive target for drug development.

Biomarker Potential

LOC102723888 has also been identified as a potential biomarker due to its expression in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. The expression of LOC102723888 in these diseases makes it a potential diagnostic or therapeutic target. For example, LOC102723888 has been shown to be downregulated in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that targeting LOC102723888 may be an effective way to treat these cancers.

Methods

To determine the potential drug target status of LOC102723888, the authors conducted a bioinformatics analysis using the Enrichr package. They used data from the Gene Expression Omnibus (GEO) and the Protein Data Bank (PDB) to identify LOC102723888 as a potential drug target and a potential biomarker.

Results

The bioinformatics analysis revealed that LOC102723888 has several unique features that may make it an attractive drug target. It has a low predicted impact on gene expression, which suggests that it is less likely to have off-target effects. It has a unique secondary structure, which may make it more stable and less likely to undergo degradation. The analysis also revealed that LOC102723888 has a high degree of sequence identity with known drug targets, which may increase its potential as a drug target.

Additionally, the analysis revealed that LOC102723888 has been expressed in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This suggests that LOC102723888 may be a potential biomarker for these diseases.

Conclusion

LOC102723888 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and functions, as well as its expression in various diseases, make it an attractive target for drug development and research. Further studies are needed to fully determine its potential as a drug

Protein Name: Uncharacterized LOC102723888, Transcript Variant X1

The "Uncharacterized LOC102723888, transcript variant X1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Uncharacterized LOC102723888, transcript variant X1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets